FDA approves drug that can slow early-stage Alzheimer's

A promising Alzheimer's drug is now getting fast-tracked by the FDA. Dr. Paul E. Schulz, the leading neurologist with UTHealth Houston and the McGovern School of Medicine, explains the benefits of Leqembi.